Compile Data Set for Download or QSAR
maximum 50k data
Found 43 Enz. Inhib. hit(s) with all data for entry = 7129
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175527(US9120744, CDE-003)
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175526(US9120744, CDE-002)
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175528(US9120744, CDE-004)
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175525(US9120744, CDE-001 (or 073))
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM92485(CDE-066 | US9120744, CDE-066)
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175546(US9120744, CDE-061)
Affinity DataIC50:  50nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175544(US9120744, CDE-058)
Affinity DataIC50:  50nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175558(US9120744, CDE-075)
Affinity DataIC50:  70nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175548(US9120744, CDE-059)
Affinity DataIC50:  90nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM92487(CDE-031 | US9120744, CDE-031)
Affinity DataIC50:  280nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM92482(CDE-008 | US9120744, CDE-008)
Affinity DataIC50:  370nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM92483(CDE-034 | US9120744, CDE-034)
Affinity DataIC50:  1.17E+3nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175552(US9120744, CDE-074)
Affinity DataIC50:  1.71E+3nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM92484(CDE-056 | US9120744, CDE-056)
Affinity DataIC50:  2.96E+3nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175534(US9120744, CDE-013)
Affinity DataIC50:  7.85E+3nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM50310301(CHEMBL599742 | N,N'-(ethane-1,2-diyl)bis(N-ethyl-3...)
Affinity DataIC50:  1.02E+4nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175542(US9120744, CDE-055)
Affinity DataIC50:  2.75E+4nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175537(US9120744, CDE-051)
Affinity DataIC50:  2.87E+4nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175549(US9120744, CDE-068)
Affinity DataIC50:  3.27E+4nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175553(US9120744, CDE-041)
Affinity DataIC50:  4.79E+4nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175557(US9120744, CDE-067)
Affinity DataIC50:  4.83E+4nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175531(US9120744, CDE-009)
Affinity DataIC50:  4.93E+4nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175551(US9120744, CDE-072)
Affinity DataIC50:  1.04E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175554(US9120744, CDE-035)
Affinity DataIC50:  1.46E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175545(US9120744, CDE-057)
Affinity DataIC50:  1.95E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175532(US9120744, CDE-012)
Affinity DataIC50:  1.96E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175538(US9120744, CDE-060)
Affinity DataIC50:  2.36E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175561(US9120744, CDE-033)
Affinity DataIC50:  2.46E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM50058812(CHEMBL302625 | N,N'-1,3-Propanediylbis(3,4,5-trihy...)
Affinity DataIC50:  2.69E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175547(US9120744, CDE-062)
Affinity DataIC50:  3.32E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175533(US9120744, CDE-011)
Affinity DataIC50:  3.38E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175535(US9120744, CDE-028)
Affinity DataIC50:  3.86E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175543(US9120744, CDE-065)
Affinity DataIC50:  4.23E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM50310300(CHEMBL606451 | N,N'-(ethane-1,2-diyl)bis(3,4-dihyd...)
Affinity DataIC50:  4.50E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175540(US9120744, CDE-069)
Affinity DataIC50:  5.62E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM50058816(CHEMBL292067 | N,N'-1,2-Ethanediylbis(3,4,5-trihyd...)
Affinity DataIC50:  9.00E+5nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM175539(US9120744, CDE-064)
Affinity DataIC50:  2.20E+6nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM92485(CDE-066 | US9120744, CDE-066)
Affinity DataKd:  3.10nMpH: 5.0 T: 2°CAssay Description:To establish binding constants for the compounds/drugs to PAI-1, an indirect approach using surface plasmon resonance (SPR) was employed. Varying con...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM92484(CDE-056 | US9120744, CDE-056)
Affinity DataKd:  51nMpH: 5.0 T: 2°CAssay Description:To establish binding constants for the compounds/drugs to PAI-1, an indirect approach using surface plasmon resonance (SPR) was employed. Varying con...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM92483(CDE-034 | US9120744, CDE-034)
Affinity DataKd:  67nMpH: 5.0 T: 2°CAssay Description:To establish binding constants for the compounds/drugs to PAI-1, an indirect approach using surface plasmon resonance (SPR) was employed. Varying con...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM92487(CDE-031 | US9120744, CDE-031)
Affinity DataKd:  31nMpH: 5.0 T: 2°CAssay Description:To establish binding constants for the compounds/drugs to PAI-1, an indirect approach using surface plasmon resonance (SPR) was employed. Varying con...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM92486(CDE-082 | US9120744, CDE-082)
Affinity DataKd:  5.30nMpH: 5.0 T: 2°CAssay Description:To establish binding constants for the compounds/drugs to PAI-1, an indirect approach using surface plasmon resonance (SPR) was employed. Varying con...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University Of Michigan

US Patent
LigandPNGBDBM92482(CDE-008 | US9120744, CDE-008)
Affinity DataKd:  23nMpH: 5.0 T: 2°CAssay Description:To establish binding constants for the compounds/drugs to PAI-1, an indirect approach using surface plasmon resonance (SPR) was employed. Varying con...More data for this Ligand-Target Pair
In DepthDetails US Patent